5Barton A,Lamb R,Symmons D,et al.Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis[J].Genes Immun,2003,4:487～491.
6Abe R,Peng T,Sailors J,et al.Regulation of the CTL response by macrophage migration inhibitory factor[J].Immunol,2001,166(2),747～753.
1Marmor MF. Hydroxychloroquine at the recommended dose ([ or=6. 5 mg/kg/day) is safe for the retina in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol, 2004, 22(2): 143-144
2Reveille JD, Alarcon GS, Fowler SE, et al. HLA- DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in rheumatoid arthritis. Arthritis Rheum, 1996, 39(11): 1802-1807
3Gerards AH, Landewe RB, Prins AP, et al. Cyclosporin A monotherapy versus cyclosporin A and metrhotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomized placebo controlled trial. Ann Rheum Dis, 2003, 62(4): 291-296
4Korpela M, Laasonen L, Hannonen P, et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease- modifying antirheumatic drugs: five- year experience from the FIN- RACo study. Arthritis Rheum, 2004, 50(7): 2072-2081
5Hallegua DS, Weisman MH. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis, 2002, 61(11): 960-967
6American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis (2002 Update). Arthritis Rheum, 2002, 46(2): 328-346
7O' Dell JR. Drug therapy: therapeutic strategies for rheumatoid arthritis. N Engl J Med, 2004, 350(25): 2591-2602
8Singh G, Ramey DR, Morfeld D, et al. Gastrointestinal tract complications of nonsteroidal anti- inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study. Arch Intern Med, 1996, 156(8): 1530-1536
9Bombardier C, Laine L, Reicin A, et al. Comparision of upper gastro- intestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med, 2000, 343(31): 1520-1528
10Jaimes- Hernandez J, Robles- San Roman M, Suarez- Otero R, et al. Rheumatoid arthritis treatment with weekly leflunomide: an open- label study. J Rheumatol, 2004, 31(2): 235-237
